• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Controlling the Clots: Current Challenges and Emerging
Controlling the Clots: Current Challenges and Emerging

... Caring for patients on anticoagulation therapy is challenging because there is a delicate balance of maintaining appropriate levels of anticoagulation while minimizing the potential risks associated with therapy. In addition, health care providers must stay up to date as new information emerges that ...
SUMMARY OF PRODUCT CHARACTERISTICS 4 CLINICAL
SUMMARY OF PRODUCT CHARACTERISTICS 4 CLINICAL

... gastrointestinal tract than aspirin. Some epidemiological studies have suggested that ...
Antiplatelet Drugs : Is There a Surgical Risk?
Antiplatelet Drugs : Is There a Surgical Risk?

... ASA is still the only nonsteroidal anti-inflammatory drug (NSAID) used in the treatment and prevention of thromboembolic diseases.15 ASA acts by irreversibly inactivating (for the life of the platelet) the enzyme cyclooxygenase (COX). This enzyme is responsible for the formation of prostaglandins an ...
Mycophenolate for Interstitial Lung Disease
Mycophenolate for Interstitial Lung Disease

... Seek urgent advice from secondary care if:  Toxicity is suspected.  Non-compliance is suspected.  The GP feels a dose change is required.  There is marked deterioration in the patient’s condition.  The GP feels the patient is not benefiting from the treatment. The shared care agreement will cea ...
Incomplete dominance and Codominance Note
Incomplete dominance and Codominance Note

... - normal red blood cells are flat and disk-shaped - sickle-shaped cells are elongated and C shaped - misshaped red blood cells do not transport oxygen effectively because they cannot pass through small blood vessels. - this leads to blockages and tissue damage ...
Clinically relevant drug interactions with antiepileptic drugs
Clinically relevant drug interactions with antiepileptic drugs

... University of Pavia, Piazza Botta 10, 27100 Pavia, Italy. ...
MIDODRINE - AA Pharma
MIDODRINE - AA Pharma

... Shy-Drager Syndrome, 17.8%; Parkinson’s disease, 11%; diabetes mellitus, 21.2%; other conditions, 23.3%). There were 245 patients who received midodrine hydrochloride in doubleblinded, placebo-controlled trials. In the placebo-controlled studies, adverse events regardless of causality were reported ...
Commissioning Support DPP-4 inhibitors (`Gliptins`)
Commissioning Support DPP-4 inhibitors (`Gliptins`)

... Commissioning guidance points for consideration:  The management of patients with type 2 diabetes involves an individualised, multifactorial approach that addresses blood pressure, blood lipids and lifestyle issues, as well as blood glucose. Controlling blood glucose requires a careful balance taki ...
Lecture 2 - H2 receptors and proton pump inhibitor 1
Lecture 2 - H2 receptors and proton pump inhibitor 1

... Acts by irreversible inhibition of proton pump (H+/ K+ ATPase) that is responsible for final step in gastric acid secretion from the parietal cell. ...
Ringwald
Ringwald

... facilitate data integration and representation of complex biological concepts Examples: B10.129-H12b is a congenic strain with the genetic background of C57BL/10Sn (=B10) which differs from that strain by the introduction of a differential allele H12b derived from strain 129/J. BXD, a set of recombi ...
Inheritance questions
Inheritance questions

... 1 A plant with red flowers is crossed with a white-flowered plant of the same species. All the seeds, when grown, produce plants with red flowers. Assuming that the flower colour is controlled by a single pair of alleles, which allele is dominant and which is recessive? _______________(1) 2 If a dom ...
King Saud University 513 PHL College of Pharmacy ID# 430203801
King Saud University 513 PHL College of Pharmacy ID# 430203801

... mg/dL) cholesterol levels. One recent 18-month, 341- patient controlled trial showed that aggressive therapy with atorvastatin (80 mg/day) was at least as effective as angioplasty plus subsequent lipid-lowering treatment in reducing the incidence of ischemic events. All statins produce a similar eff ...
new oral anticoagulant drugs (noac) and their
new oral anticoagulant drugs (noac) and their

... These drugs are new to market and the potential long‐term side effects are not yet fully known. Concerns also include that  the optimal method of emergency reversal of the anticoagulant effects of these agents is currently unclear in those patients  who present with major bleeding. There are also co ...
alleles: t
alleles: t

... • Mendel’s MODEL OF HEREDITY does account for such ___________ ...
PDF - Bentham Open
PDF - Bentham Open

... lovastatin is based on its electrophoretic mobility in the aqueous medium [6, 10]. Suresh et al. have studied the average size and zeta potential of lovastatin nanoparticles at 250C at an electric field strength of 23.2 V/cm at different pH values (pH 6.9 to 7.2). They determined the average size an ...
“GENE-STICKS”
“GENE-STICKS”

... Answer the following questions: a) Each pair of sticks represents a _________________________. b) Two sticks of the same size & containing the same types of characteristics are called ________________________. c) Each piece of tape represents the location of a _______________________, which is a se ...
What is Population Genetics?
What is Population Genetics?

... • Europe, North America ...
Ursodex - The IBN SINA Pharmaceutical Industry Ltd.
Ursodex - The IBN SINA Pharmaceutical Industry Ltd.

... No evidence of harm has been reported in pregnancy. It has been effectively used for the treatment of cholestasis of pregnancy during the last trimester without any side effects. Lactation: Problems have not been documented in humans regarding breast feeding. So patients taking the drug during breas ...
document
document

... similar study that had negative results. Company submitted both studies confidentially to FDA and FDA rejected pediatric approval for the drug based on the negative study. Negative study did not become public until the New York Times published an article about it several years later.  Company promo ...
A Patient With an Inborn Error of Vitamin B12
A Patient With an Inborn Error of Vitamin B12

... Several have had decreased serum vitamin B12 levels, apparently reflecting a role for the lysosome in intestinal uptake of ingested cobalamin; the Schilling test for cobalamin absorption has been reported to be abnormal in cblF patients.6 A second disorder with an identical biochemical and cellular p ...
Risk Evaluation and Mitigation Strategies (REMS): Building a
Risk Evaluation and Mitigation Strategies (REMS): Building a

... outlined four priority projects that it will pursue, one of which focuses on improving providerpatient benefit-risk counseling for drugs that have a REMS. Through this project, FDA aims to support the standardization of effective benefit-risk counseling between providers and patients, encourage prov ...
Salt-Wasting Congenital Adrenal Hyperplasia: Detection of
Salt-Wasting Congenital Adrenal Hyperplasia: Detection of

... based on the 8-bp deletion in exon 3 present only in the pseudogene (CYP21A). The PCR reactions rendered two fragments, one encompassing exons 1–3 and the other exons 4 –10 of the CYP21B gene. These fragments were used in a second round of amplification to detect the different mutations. For each mu ...
GENOTYPE, PHENOTYPE AND GENE FREQUENCIES
GENOTYPE, PHENOTYPE AND GENE FREQUENCIES

... homozygotes are very rare and can be ignored for the sake of calculations. As almost all patients are heterozygous with one normal and one abnormal allele, the frequency of the mutant allele (q) is approx. half the disease incidence (2 pq or almost 2q since p is very nearly 1) e.g. familial hypercho ...
Labelling of injectable medicines administered in anaesthesia
Labelling of injectable medicines administered in anaesthesia

... 1.2.1. The stockage of medicaments must be organized and standardized in all the operating rooms, drawers and cupboards, carts, trays or other devices used to identify them correctly and to avoid confusion. 1.2.2. There must be a limit for the amount of drugs and its presentations. If possible, it s ...
Investor Presentation
Investor Presentation

... Regular doses of low-dose naltrexone can be used to increase a patient's endorphin and enkephalin levels. The interaction of naltrexone with microglia cells within the central nervous system is believed to be how the drug exerts its beneficial effects in individuals who suffer from fibromyalgia; thi ...
< 1 ... 696 697 698 699 700 701 702 703 704 ... 1254 >

Pharmacogenomics

Pharmacogenomics (a portmanteau of pharmacology and genomics) is the study of the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Through the utilization of pharmacogenomics, it is hoped that drug treatments can deviate from what is dubbed as the “one-dose-fits-all” approach. It attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient’s genes, the functionality of these genes, and how this may affect the efficacy of the patient’s current and/or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of ""personalized medicine""; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Whether used to explain a patient’s response or lack thereof to a treatment, or act as a predictive tool, it hopes to achieve better treatment outcomes, greater efficacy, minimization of the occurrence of drug toxicities and adverse drug reactions (ADRs). For patients who have lack of therapeutic response to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic-based recommendations for a given drug, two possible types of input can be used: genotyping or exome or whole genome sequencing. Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early stop codon).
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report